Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

16 projects found matching your search criteria :

  1. COX-2 inhibitors and/or PPAR agonists-conjugated PAMAM G3 dendrimers targeted into cancer cells. Biological properties a...

    Call: SONATA 7 , Panel: NZ3

    Principal investigator: dr Łukasz Uram

    Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Chemiczny

  2. Investigating the regulatory relationships between RNA metabolism and biotic stress defense in Arabidopsis thaliana.

    Call: OPUS 7 , Panel: NZ3

    Principal investigator: dr Anna Golisz

    Uniwersytet Warszawski, Wydział Biologii

  3. East Pamir's wetlands:their occurence, hydrological and ecological characteristics and sustainability.

    Call: OPUS 5 , Panel: ST10

    Principal investigator: dr hab. Małgorzata Suska-Malawska

    Uniwersytet Warszawski, Wydział Biologii

  4. PAMAM G4 and G3,5 dendrimers as potential carriers of oncological drugs

    Call: OPUS 4 , Panel: ST4

    Principal investigator: prof. Henryk Piekarski

    Uniwersytet Łódzki, Wydział Chemii

  5. Study of the interactions between PAMAM G5 and PAMAM G5-OH dendrimers and selected oncological drugs

    Call: PRELUDIUM 3 , Panel: ST4

    Principal investigator: dr Adam Buczkowski

    Uniwersytet Łódzki, Wydział Chemii

  6. Pattern-Specific Inhibitors (PSI) - introduction and basic characteristics of a new class of inhibitors that block recog...

    Call: OPUS 3 , Panel: NZ6

    Principal investigator: dr Krzysztof Guzik

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  7. Mechanisms of contact sensitivity response (CS) mediated via NK cells activated by Toll like receptor (TLR) ligands in m...

    Call: OPUS 2 , Panel: NZ6

    Principal investigator: dr Monika Majewska-Szczepanik

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Nauk o Zdrowiu

  8. Influence of GaN crystal anisotropy on the properties of InGaN and AlGaN layers and quantum structures on nonpolar (10-1...

    Call: PRELUDIUM 2 , Panel: ST3

    Principal investigator: dr Marta Sawicka

    Instytut Wysokich Ciśnień PAN

  9. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Krzysztof Kamiński

    Uniwersytet Jagielloński, Collegium Medicum

  10. FGF/FGFR-signalling in mediation of resistance to therapy in triple-positive breast cancer: clinical implications of PAM...

    Call: OPUS 20 , Panel: NZ4

    Principal investigator: dr hab. Hanna Romańska-Knight

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  11. Mutations in TP53 gene in canine mammary tumor and their clinical significance.

    Call: PRELUDIUM 17 , Panel: NZ4

    Principal investigator: Katarzyna Roszkowska

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Wydział Medycyny Weterynaryjnej

  12. PAMAM dendrimer as carrier for mesalazine to enhance the efficacy of inflammatory bowel disease therapy - in vitro studi...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Michał Gorzkiewicz

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  13. Comparative analysis of intrinsic molecular subtypes as defined by PAM50 of circulating, primary and metastatic tumour c...

    Call: PRELUDIUM 15 , Panel: NZ4

    Principal investigator: Marcin Braun

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  14. Functional hybrid nanomaterials based on poly(amidoamine) PAMAM dendrimers.

    Call: PRELUDIUM 12 , Panel: ST4

    Principal investigator: Karolina Tokarczyk

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera Polskiej Akademii Nauk

  15. Dendimers as a platform for designing biologically active carrier

    Call: OPUS 12 , Panel: ST5

    Principal investigator: prof. Barbara Jachimska

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera Polskiej Akademii Nauk

  16. Nanoparticle conjugates with the monoclonal antibody - a new opening in target tumor therapy

    Call: PRELUDIUM 10 , Panel: NZ3

    Principal investigator: Monika Marcinkowska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska